INTERNATIONAL PATENT: MEDIOGEN CO.,LTD., 주식회사 메디오젠 FILES APPLICATION FOR "LEVILACTOBACILLUS BREVIS MG5552 STRAIN HAVING EXCELLENT GABA-PRODUCING ABILITY AND USE THEREOF FOR ALLEVIATING SEIZURES, CONVULSIONS, EPILEPSY, SLEEP DISORDERS AND STRESS"

GENEVA, Jan. 6 -- MEDIOGEN CO.,LTD. (120, Bio valley 1-ro,Jecheon-siChungcheongbuk-do 27159), 주식회사 메디오젠 (충청북도제천시바이오밸리1로 120) filed a patent application (PCT/KR2024/017542) for "LEVILACTOBACILLUS BREVIS MG5552 STRAIN HAVING EXCELLENT GABA-PRODUCING ABILITY AND USE THEREOF FOR ALLEVIATING SEIZURES, CONVULSIONS, EPILEPSY, SLEEP DISORDERS, AND STRESS" on Nov 07, 2024. With publication no. WO/2026/005150, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is manage...